Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines
LONDON, Sept. 5, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Clinical Trial Patient Recruitment Services Market (3rd Edition), 2022-2035" report to its list of offerings.
Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. Presently, more than 155 companies have the required capabilities to offer patient recruitment and retention services across different geographical locations. Such clinical trial recruitment companies employ a variety of outreach methods and, over time, have attained a vital role in the successful conduct of clinical research. Further, several contract service providers are entering into strategic alliances in order to enhance their respective capabilities and offer an expanded portfolio of services to their clients. One such example is the collaboration of Trialbee and Worldwide Clinical Trials. The two companies announced their partnership in May 2021, which was aimed at faster patient recruitment and bringing down the cost of drug development for their clients.
To order this 350+ page report, which features 95+ figures and 140+ tables, please visit our Clinical Trial Patient Recruitment Services Market Report
Key Market Insights
- Currently, over 150 companies claim to offer patient recruitment and retention services to the pharmaceutical and medical device industries, using a variety of conventional and innovative outreach methods
- The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions
- Most of the companies offer pre-screening of the potential study candidates and protocol development services to their clients; providing study-branded amenities is the most popular patient retention strategy
- In order to gain a competitive edge and cater to the requirements of the clients, firms are actively improving their capabilities and enhancing their respective service portfolios
- The increasing preference of trial sponsors to outsource patient recruitment-related activities is evident from the increase in partnership activity; in fact, more than 35% of the deals were forged in the last three years
- Rising clinical research activity, specifically focused on rare and complex disease indications, is anticipated to create lucrative business opportunities for patient recruitment and retention service providers
- The demand for participants in clinical research is rising, and gradually becoming more complex owing to stringent regulatory guidelines; by 2035, around 21 million patients are expected to be enrolled in clinical trials
- The market is expected to grow at a CAGR of 8.2% till 2035; the projected opportunity is likely to be well distributed across different steps in the patient recruitment process, trial phase and therapeutic area
- In terms of annual service revenues, North America is likely to capture majority share in the patient recruitment market; however, Asia Pacific is anticipated to grow at a higher rate compared to other geographies
For additional details, please visit https://www.rootsanalysis.com/reports/patient-recruitment-and-retention-services-market/245.html
The financial opportunity within the patient recruitment and retention services market has been analyzed across the following segments:
- Patient Recruitment Step
- Pre-screening
- Screening
- Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Therapeutic Area
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Diseases
- CNS Disorders
- Respiratory Disorders
- Hematological Disorders
- Dermatological Disorders
- Ophthalmic Disorders
- Others
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
The report also features inputs from eminent industry stakeholders, according to whom, the continuously growing demand for patients and the increasing preference for outsourcing is likely to drive the growth of the overall patient recruitment and retention services market, in the foreseen future. The report includes detailed transcripts of discussions held with the following experts:
- Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
- Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
- Simon Klaasen (Co-founder and Managing Director, Link2Trials)
- Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
- Ken Shore (Chief Commercial Officer, Continuum Clinical)
- Hagit Nof (Ex-Chief Operation Officer and Business Development Officer, nRollmed)
- Paul Ivsin (Ex-Managing Director, Seeker Health)
- Kasturi Lakhe (Inside Sales Specialist, EVERSANA)
The research includes profiles of the key players (listed below); each profile features a brief overview of the company, its financial performance (if available), recent developments and an informed future outlook.
- BBK Worldwide
- Continuum Clinical
- IQVIA
- United BioSource (UBC)
- WCG ThreeWire
- Clariness
- Fidelis Research
- Ignite Data
- Innovative Trials
- Orphan Reach
- 3H Medi Solution
- Buzzreach
- Current Medical Information Center (CMIC)
- nRollmed
- Trialfacts
Key Questions Answered
- Who are the key players engaged in offering patient recruitment and retention services?
- What are the current opportunities within the patient recruitment and retention services market?
- What is the relative competitiveness of patient recruitment and retention service providers?
- What types of partnership models are commonly adopted by stakeholders in this industry?
- What is the overall demand of patients for recruitment in the ongoing clinical trials?
- What are the key challenges faced by patient recruitment and retention service providers?
- What are the key market trends and driving factors that are likely to impact this market?
- What is the current / likely future market size of patient recruitment and retention services market?
Table of Contents
- Preface
- Executive Summary
- Introduction
- Patient Outreach Methods
- Market Landscape
- Company Competitiveness Analysis
- Company Profiles: Patient Recruitment and Retention Services Providers in North America
- Company Profiles: Patient Recruitment and Retention Services Providers in Europe
- Company Profiles: Patient Recruitment and Retention Services Providers in Asia-Pacific and Rest of The World
- Partnerships and Collaborations
- Recent Trends in Patient Recruitment and Retention
- Future Growth Opportunities in Patient Recruitment
- Case Study: Regulatory Landscape of Patient Recruitment
- Patient Recruitment in Trials Focused on Personalized Medicines and Rare Diseases
- Analysis of Demand for Clinical Trial Participants
- Market Sizing and Opportunity Analysis
- Concluding Remarks
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
For additional details, please visit https://www.rootsanalysis.com/reports/patient-recruitment-and-retention-services-market/245.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
- Biopharmaceutical Contract Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
- ADC Contract Manufacturing Market (5th Edition): Industry Trends and Global Forecasts, 2022-2035
- Gene Therapy Market: Industry Trends and Global Forecasts, 2022-2035
- Continuous Manufacturing (Small Molecules and Biologics) Market (2nd Edition): Industry Trends and Global Forecasts, 2022-2035
- Peptide Therapeutics: Contract API Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
- Lyophilization Services Market for Biopharmaceuticals: Industry Trends and Global Forecasts, 2022-2035
- Nanoparticles Contract Manufacturing (Focus on Lipid and Metal Nanoparticles) Market: Industry Trends and Global Forecasts, 2021-2035
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com
Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
View original content:
Voltar noticias em Inglês